PK of 4 prototype formulations of Lorcaserin (QBR115165)

• Research type

  Research Study

• Full title

  An Open-Label, Five Period, Fixed Sequence, Non-Randomised Study in 12 Healthy Subjects Designed to Evaluate the Pharmacokinetic Performance of up to Four Modified Release Prototype Formulations of Lorcaserin

• IRAS ID

  133187

• Contact name

  Stuart Mair

• Contact email

  stuart.mair@quotientclinical.com

• Sponsor organisation

  Arena Pharmaceuticals

• Eudract number

  2013-002019-85

• ISRCTN Number

  To be registered

• REC name

  Wales REC 2

• REC reference

  13/WA/0232

• Date of REC Opinion

  19 Jul 2013

• REC opinion

  Favourable Opinion